These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 16582560)

  • 1. [Efficacy and safety of Padma 28 in peripheral arterial occlusive disease].
    Melzer J; Brignoli R; Saller R
    Forsch Komplementmed; 2006 Feb; 13 Suppl 1():23-7. PubMed ID: 16582560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating intermittent claudication with Tibetan medicine Padma 28: does it work?
    Melzer J; Brignoli R; Diehm C; Reichling J; Do DD; Saller R
    Atherosclerosis; 2006 Nov; 189(1):39-46. PubMed ID: 16600251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical studies on the efficacy and safety of Padma 28, a complex herbal formulation from Tibetan medicine: an overview.
    Vennos C; Melzer J; Saller R
    Forsch Komplementmed; 2013; 20 Suppl 2():25-30. PubMed ID: 23860110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical studies in peripheral arterial occlusive disease: update from the aspects of a meta-narrative review].
    Melzer J; Saller R
    Forsch Komplementmed; 2013; 20 Suppl 2():17-21. PubMed ID: 23860108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Padma 28 for intermittent claudication.
    Morling JR; Maxwell H; Stewart M
    Cochrane Database Syst Rev; 2013 Jul; (7):CD007371. PubMed ID: 23861015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Tibetan herbal formula Padma Digestin in functional dyspepsia: an open-label study.
    Meier R; Hengstler P; Weber F; Maurer H; Bommeli C; Brignoli R
    Forsch Komplementmed; 2013; 20 Suppl 2():2-7. PubMed ID: 23860105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-inflammatory potential of Padma 28--review of experimental data on the antiatherogenic activity and discussion of the multi-component principle].
    Ueberall F; Fuchs D; Vennos C
    Forsch Komplementmed; 2006 Feb; 13 Suppl 1():7-12. PubMed ID: 16582557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Padma 28--a useful supplement in the treatment of peripheral arterial occlusive disease in the stages IIa and IIb].
    Regli C; Groechenig E
    Forsch Komplementmed; 2013; 20 Suppl 2():22-4. PubMed ID: 23860109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of the Tibetan herbal preparation Padma 28 in intermittent claudication].
    Schräder R; Nachbur B; Mahler F
    Schweiz Med Wochenschr; 1985 Jun; 115(22):752-6. PubMed ID: 3892663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The Tibetan formula Padma Lax in medical practice: a retrospective case series study in constipation including 174 patients].
    Uehleke B; Zahradnicek S; Vennos C
    Forsch Komplementmed; 2013; 20 Suppl 2():8-13. PubMed ID: 23860106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral arterial occlusive disease: conservative treatment of intermittent claudication.
    Kriessmann A
    J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S72-4. PubMed ID: 1369724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new study demonstrates the efficacy of naftidrofuryl in the treatment of intermittent claudication. Findings of the Naftidrofuryl Clinical Ischemia Study (NCIS).
    Kieffer E; Bahnini A; Mouren X; Gamand S
    Int Angiol; 2001 Mar; 20(1):58-65. PubMed ID: 11342997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Padma-28, a herbal preparation, increases walking distance in patients with intermittent claudication].
    Drabaek H; Mehlsen J; Petersen JR; Himmelstrup H; Hansen KF
    Ugeskr Laeger; 1994 Oct; 156(42):6207-9. PubMed ID: 7998359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a 4-week treatment with prostaglandin E1 on plasma endothelin-1 release in patients with intermittent claudication.
    Mangiafico RA; Malatino LS; Santonocito M; Messina R; Attinà T; Dell'Arte S; Sarnataro F
    Int J Clin Pharmacol Ther; 1999 Jul; 37(7):347-51. PubMed ID: 10442509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis: phytotherapy of functional dyspepsia with the herbal drug preparation STW 5 (Iberogast).
    Melzer J; Rösch W; Reichling J; Brignoli R; Saller R
    Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1279-87. PubMed ID: 15606389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory mechanisms of the Tibetan herbal preparation Padma 28 in the vessel wall.
    Exner M; Raith M; Holzer G; Gmeiner B; Wagner O; Kapiotis S
    Forsch Komplementmed; 2006 Feb; 13 Suppl 1():13-7. PubMed ID: 16582558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A botanical compound, Padma 28, increases walking distance in stable intermittent claudication.
    Drabaek H; Mehlsen J; Himmelstrup H; Winther K
    Angiology; 1993 Nov; 44(11):863-7. PubMed ID: 8239057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trials of endovascular treatment for superficial femoral artery occlusive lesions: a call for medically managed control patients.
    Wilson SE
    Ann Vasc Surg; 2010 May; 24(4):498-502. PubMed ID: 20036508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of intermittent claudication with pentoxifylline: meta-analysis of randomized controlled trials.
    Hood SC; Moher D; Barber GG
    CMAJ; 1996 Oct; 155(8):1053-9. PubMed ID: 8873633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of intermittent claudication with mesoglycan--a placebo-controlled, double-blind study.
    Nenci GG; Gresele P; Ferrari G; Santoro L; Gianese F;
    Thromb Haemost; 2001 Nov; 86(5):1181-7. PubMed ID: 11816704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.